Cambridge Investment Research Advisors’s AllianzIM 6 Month Buffer10 Allocation ETF SPBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.15M Buy
176,710
+7,121
+4% +$203K 0.01% 1022
2026
Q1
$4.57M Sell
169,589
-27,704
-14% -$763K 0.01% 1017
2025
Q4
$5.42M Buy
197,293
+41,834
+27% +$1.13M 0.01% 887
2025
Q3
$4.18M Buy
155,459
+60,148
+63% +$1.59M 0.01% 1015
2025
Q2
$2.47M Buy
+95,311
New +$2.36M 0.01% 1268

Other funds holding SPBX

Cambridge Investment Research Advisors's SPBX Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its AllianzIM 6 Month Buffer10 Allocation ETF (SPBX) stake by 4.2% in Q2 2026, buying an estimated $203K and bringing the position to 176,710 shares worth $5.15M. The position accounts for 0.01% of the portfolio, ranked #1022.

Cambridge Investment Research Advisors first reported a position in SPBX in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.42M in Q4 2025. 27 funds tracked by Wall St. Rank hold SPBX as of Q2 2026.

  • Cambridge Investment Research Advisors held 176,710 shares of AllianzIM 6 Month Buffer10 Allocation ETF worth $5.15M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 7,121 AllianzIM 6 Month Buffer10 Allocation ETF shares in Q2 2026, an estimated $203K.
  • AllianzIM 6 Month Buffer10 Allocation ETF made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1022 holding.
  • Cambridge Investment Research Advisors first reported a position in AllianzIM 6 Month Buffer10 Allocation ETF in Q2 2025 and has held it in 5 quarters since.
  • Cambridge Investment Research Advisors's AllianzIM 6 Month Buffer10 Allocation ETF position peaked at $5.42M in Q4 2025.
  • 27 funds tracked by Wall St. Rank held AllianzIM 6 Month Buffer10 Allocation ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.